These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25432985)

  • 1. PDE2 activity differs in right and left rat ventricular myocardium and differentially regulates β2 adrenoceptor-mediated effects.
    Soler F; Fernández-Belda F; Pérez-Schindler J; Handschin C; Fuente T; Hernandez-Cascales J
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1205-13. PubMed ID: 25432985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single inhibition of either PDE3 or PDE4 unmasks β2-adrenoceptor-mediated inotropic and lusitropic effects in the left but not right ventricular myocardium of rat.
    Soler F; Fernández-Belda F; Pérez-Schindler J; Hernández-Cascales J
    Eur J Pharmacol; 2015 Oct; 765():429-36. PubMed ID: 26364538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterases inhibition unmask a positive inotropic effect mediated by beta2-adrenoceptors in rat ventricular myocardium.
    Gonzalez-Muñoz C; Fuente T; Hernández-Cascales J
    Eur J Pharmacol; 2009 Apr; 607(1-3):151-5. PubMed ID: 19239906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
    Juan-Fita MJ; Vargas ML; Hernández J
    Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
    Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
    Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase PDE2 activity, increased by isoprenaline, does not reduce β-adrenoceptor-mediated chronotropic and inotropic effects in rat heart.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Jun; 391(6):571-585. PubMed ID: 29556684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increase in rat ventricular automaticity induced by salbutamol is mediated through β(1)- but not β(2)-adrenoceptors: role of phosphodiesterases.
    Gonzalez-Muñoz C; Fuente T; Medin-Aguerre S; Hernández-Cascales J
    Life Sci; 2011 Jun; 88(25-26):1095-101. PubMed ID: 21565204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure leads to altered β2-adrenoceptor/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman/Na,K ATPase microdomain.
    Bastug-Özel Z; Wright PT; Kraft AE; Pavlovic D; Howie J; Froese A; Fuller W; Gorelik J; Shattock MJ; Nikolaev VO
    Cardiovasc Res; 2019 Mar; 115(3):546-555. PubMed ID: 30165515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
    Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of phosphodiesterases PDE2, PDE3, and PDE4 do not increase the sinoatrial tachycardia of noradrenaline and prostaglandin PGE₁ in mice.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):177-86. PubMed ID: 26531832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
    Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
    Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
    Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
    Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
    Galindo-Tovar A; Kaumann AJ
    Br J Pharmacol; 2008 Feb; 153(4):710-20. PubMed ID: 18084319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats.
    Doggrell SA
    J Pharm Pharmacol; 2002 Oct; 54(10):1407-12. PubMed ID: 12396304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diazepam potentiates the effects of endogenous catecholamines on contractility and cyclic AMP levels in rat ventricular myocardium.
    Marín J; Hernández J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):260-8. PubMed ID: 11919649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.